What We Don’t Hear About GLP-1s: Mental Health & Identity with Kate Lyman
Description
Are you considering GLP-1 medications like Semaglutide, Tirzepatide, or Zepbound for weight loss, or do you know someone who is? This conversation provides a nuanced conversation about GLP-1s and considerations around starting them.
In this episode, host Nikki Naab-Levy chats with Kate Lyman, a nutrition coach with a Master's in public health about the unspoken potential ramifications of using these drugs, from a mental health and behavior change perspective.
In this episode, you’ll learn:
-
The difference between the clinical and social media definitions of "food noise".
-
Why weight loss on a GLP-1 does not automatically equate to better body image or health.
-
The potential for GLP-1s to replace "food noise" with new fixations or obsessions in (e.g., scale-watching, body composition) in some individuals.
-
The mixed mental health outcomes of GLP-1s, including studies linking them to an elevated risk of anxiety, major depression, and suicidal behavior <span style="font-size: 11pt; font-family: 'Google Sans Text',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none;
United States
